Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia

Laurence C. Cheung
, Mark N. Cruickshank
, Anastasia M. Hughes
, Sajla Singh
, Grace-Alyssa Chua
, Jette Ford
, Emanuela Ferrari
, Joyce Oommen
, Sebastien Malinge
, Richard B. Lock
, Ursula R. Kees
, Rishi S. Kotecha

Research output: Contribution to journal › Letter › peer-review

16 Citations (Scopus)

1 results

Finished

Combinatorial therapeutics in high-risk infant acute lymphoblastic leukaemia
Kotecha, R. (Investigator 01)
NHMRC National Health and Medical Research Council
1/01/18 → 31/12/21
Project: Research